Skip to main content
OpenTrials
Completed

NCT Number: NCT01198470

TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study

The purpose of this investigation is to evaluate the safety and effectiveness of the TRIUMPH® Lumbar Artificial Disc for the treatment of patients who are suffering from Degenerative Disc Disease (DDD) at one level from L1 to S1.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Degenerative Disc Disease in one vertebral level between L1 and S1
  • Able to understand and sign informed consent
  • Had at least 6 months of conservative treatment
  • Oswestry Disability Index Score of at least 30 (one a 100 point scale)
  • Other inclusion criteria as specified in approved IDE protocol

Exclusion criteria

  • Bilateral leg pain
  • Back or leg pain of unknown etiology
  • Prior fusion surgery or another spinal device implanted at any other lumbar level
  • Osteoporosis or osteopenia
  • Other exclusion criteria as specified in approved IDE protocol

Treatment and study plan

TRIUMPH® Lumbar Artificial Disc

Device

The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.

Primary outcomes

  1. Number of Participants With a Change of at Least 15 Points in Pain/Disability Using the Oswestry Disability Index (ODI) Score at 24 Months Compared With the Score at Baseline

    Time frame: 24 months

    The Oswestry Disability Index (ODI) is a commonly used outcome-measure questionnaire for low back pain in a hospital setting. It is a self-administered questionnaire divided into ten sections designed to assess limitations of various activities of daily living. Each section is scored on a 0-5 scale, 5 representing the greatest disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.

  2. Number of Participants With No Device Failures

    Time frame: 24 months

    Any device requiring surgical revision, reoperation, removal or supplemental fixation will be considered a device failure

  3. Number of Participants With Major Complications Defined as Major Vessel Injury or Neurological Damage

    Time frame: 24 months

    Major vessel injury is defined as injury of the aorta or vena cava or other major vessels (e.g. iliac arteries, superior rectal artery, iliac veins, and their branches), caused by the surgery or device, resulting in significant blood loss or requiring additional surgery to correct. Neurological damage is defined as damage to the spinal cord or a nerve root caused by the surgery or device, resulting in neurologic deficit that persists for more than 3 months and is without improvement, is progressive, or involves motor loss. Major complications are reported on adverse event case report forms.

  4. Number of Participants Determined to Have a Normal Neurological Status

    Time frame: 24 months

    Neurological status was assessed using a neurological status scale, which is based on four types of measurement parameters: motor, sensory, reflexes, and straight leg raise. The method for summarizing neurological status is described below. Each parameter (i.e. motor, sensory, reflexes, straight leg raise) is coded as follows:

    Motor 0 Total Paralysis

    • Palpable or Visible Contraction
    • Active Movement, Gravity Eliminated
    • Active Movement, Against Gravity
    • Active Movement, Against Some Resistance
    • Active Movement, Against Full Resistance

    Sensory 0 Absent

    • Impaired
    • Normal

    Reflexes 0 Absent or Trace

    • Hyper-reflexive
    • Normal or hypo-reflexive

    Straight Leg Raise 0 0° - 70° (Abnormal)

    1 > 70°-90° (Normal)

    If all evaluations for the parameter are determined to be normal, then the parameter is given a normal status. If any evaluations for the parameter are abnormal, then the parameter is given an abnormal status.

Sponsors and collaborators

Lead sponsor

Globus Medical Inc

Industry

Registry information

Official study title

A Prospective Clinical Investigation of the TRIUMPH Lumbar Disc: A Pilot Study

Important dates

Study start
2010
Primary completion
2016
Study completion
2016
First posted
Sep 10, 2010
Registry last updated
Oct 2, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.